ENgineered CArtilage from Nose for the Treatment of Osteoarthritis (ENCANTO)

Informazioni relative al progetto

ENCANTO

ID dell’accordo di sovvenzione: 101137315

DOI

10.3030/101137315

Data della firma CE 11 Dicembre 2023

Data di avvio 1 Gennaio 2024

Data di completamento 31 Dicembre 2029

Finanziato da

• Health

Costo totale

€ 8 363 555,00

Contributo UE

€ 8 363 555,00

Coordinato da

FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO MEDICO
Italy

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (2)

Definition and implementation of digital rehabilitation program and monitoring

Defined rehabilitation program with corresponding videos and detailed instructions in all languages implemented in the online platform. Digital monitoring and data acquisitionimplemented in the rehabilitation protocol on four levels: 1) ability to perform a specific task within dailyprotocol, 2) VAS pain score on daily basis, 3) traffic light system and 4)Bassett patient self-report scales for elapsed rehabilitation week.

Dissemination and Communication Plan first version

Dissemination and Communication plan report

Websites, patent fillings, videos etc. (1)

Project Website

The public website of the project.

Pubblicazioni

Conference proceedings (2)

Nose to knee. State of Art in clinical application of GMP products of nasal chondrocytes

Autori: Marcus Mumme
Pubblicato in: TERMIS EU 2025 Freiburg
Editore: N/A

Early Osteoarthritic Lesions: A Therapeutic Dead-End or an Opportunity?

Autori: Marcus Mumme
Pubblicato in: Annual Congress Swiss Orthopaedics Zurich, 2025
Editore: N/A

Peer reviewed articles (4)

White paper – A proposal towards objective biomechanical metrics as novel endpoints to document improvements in musculoskeletal function and mobility

Autori: Sónia A. Alves, Nicholas M. Brisson, Alison N. Agres, Mark Heyland, Ali Mobasheri, David J. Hunter, Tobias Winkler, Georg N. Duda
Pubblicato in: Osteoarthritis and Cartilage Open, Numero 7, 2025, ISSN 2665-9131
Editore: Elsevier BV
DOI: 10.1016/J.OCARTO.2025.100648

Insights into chondrocyte populations in cartilaginous tissues at the single-cell level

Autori: Csaba Matta, Roland Takács, Mona Dvir-Ginzberg, Stephen M. Richardson, Karoliina Pelttari, Girish Pattappa, Makarand V. Risbud, Ali Mobasheri
Pubblicato in: Nature Reviews Rheumatology, Numero 21, 2025, ISSN 1759-4790
Editore: Springer Science and Business Media LLC
DOI: 10.1038/S41584-025-01275-0

Gene therapy pipelines for osteoarthritis: current innovations, operational challenges, and future directions

Autori: Valtteri Peitso, Karman Ng, Ron Ellis, Jean-Yves Reginster, Christopher H. Evans, Ali Mobasheri
Pubblicato in: Connective Tissue Research, 2025, ISSN 0300-8207
Editore: Informa UK Limited
DOI: 10.1080/03008207.2025.2520319

Clinical relevance of engineered cartilage maturation in a randomized multicenter trial for articular cartilage repair

Autori: Marcus Mumme, Anke Wixmerten, Alan Ivkovic, Giuseppe M. Peretti, Tayfun Yilmaz, Stephan Reppenhagen, Oliver Pullig, Sylvie Miot, Kaywan Izadpanah, Marcel Jakob, Laura Mangiavini, Corrado Sosio, Filip Vuletić, Oliver Bieri, Stefano Biguzzi, Brigitta Gahl, Gyözö Lehoczky, Rudolf Vukojevic, Sebastian Häusner, Anna Gryadunova, Martin Haug, Andrea Barbero, Ivan Martin
Pubblicato in: Science Translational Medicine, Numero 17, 2025, ISSN 1946-6234
Editore: American Association for the Advancement of Science (AAAS)
DOI: 10.1126/SCITRANSLMED.ADS0848